Cleland JG - Search Results

1

Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF.

Suzuki T, Yazaki Y, Voors AA, Jones DJL, Chan DCS, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, Metra M, Ng LL. Suzuki T, et al. Among authors: cleland jg. Eur J Heart Fail. 2019 Jul;21(7):877-886. doi: 10.1002/ejhf.1338. Epub 2018 Oct 29. Eur J Heart Fail. 2019. PMID: 30370976 Free article.

2

Mortality in heart failure: clinical variables of prognostic value.

Cleland JG, Dargie HJ, Ford I. Cleland JG, et al. Br Heart J. 1987 Dec;58(6):572-82. doi: 10.1136/hrt.58.6.572. Br Heart J. 1987. PMID: 2447925 Free PMC article.

3

The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.

Cleland JG, Gillen G, Dargie HJ. Cleland JG, et al. Eur Heart J. 1988 Feb;9(2):132-41. doi: 10.1093/oxfordjournals.eurheartj.a062466. Eur Heart J. 1988. PMID: 2832173 Review.

4

Ventricular arrhythmias during exercise in patients with heart failure: the effect of amiodarone.

Cleland JG, Dargie HJ. Cleland JG, et al. Eur Heart J. 1987 Aug;8 Suppl D:65-9. doi: 10.1093/eurheartj/8.suppl_d.65. Eur Heart J. 1987. PMID: 3678263 Clinical Trial.

5

Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II?

Good JM, Nihoyannopoulos P, Ghatei MA, Crossman D, Bloom SR, Clark P, Oakley CM, Cleland JG. Good JM, et al. Among authors: cleland jg. Eur Heart J. 1994 Dec;15(12):1634-40. doi: 10.1093/oxfordjournals.eurheartj.a060446. Eur Heart J. 1994. PMID: 7698133 Clinical Trial.

6

The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials.

Cleland JG. Cleland JG. Eur Heart J. 1994 Jan;15(1):125-30. doi: 10.1093/oxfordjournals.eurheartj.a060364. Eur Heart J. 1994. PMID: 8174572 Review.

7

Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure.

Dutka DP, Olivotto I, Ward S, Nihoyannopoulos P, al-Subaili M, Oakley CM, Impallomeni M, Cleland JG. Dutka DP, et al. Among authors: cleland jg. Eur Heart J. 1995 Sep;16(9):1223-30. doi: 10.1093/oxfordjournals.eurheartj.a061079. Eur Heart J. 1995. PMID: 8582385

8

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity.

Narang R, Swedberg K, Cleland JG. Narang R, et al. Among authors: cleland jg. Eur Heart J. 1996 Jan;17(1):120-34. doi: 10.1093/oxfordjournals.eurheartj.a014670. Eur Heart J. 1996. PMID: 8682118 Review.

9

Mode of death in chronic heart failure. A request and proposition for more accurate classification.

Narang R, Cleland JG, Erhardt L, Ball SG, Coats AJ, Cowley AJ, Dargie HJ, Hall AS, Hampton JR, Poole-Wilson PA. Narang R, et al. Among authors: cleland jg. Eur Heart J. 1996 Sep;17(9):1390-403. doi: 10.1093/oxfordjournals.eurheartj.a015074. Eur Heart J. 1996. PMID: 8880025 Review.

10

Beta-blocking agents in heart failure. Should they be used and how?

Cleland JG, Bristow MR, Erdmann E, Remme WJ, Swedberg K, Waagstein F. Cleland JG, et al. Eur Heart J. 1996 Nov;17(11):1629-39. doi: 10.1093/oxfordjournals.eurheartj.a014745. Eur Heart J. 1996. PMID: 8922910 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,176 results

Search Page

Filters